Robert A Quint, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 13
- 1 carrier
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Quint’s office at (408) 275-9410 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A35335 · Delinquent
Licence status: Delinquent · since 1980 · expires 2025-12-31 · University of Baghdad College of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$88,929
Medicare paid this office $88,929 for 100 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 76 | $32,003 | $111 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 14 | $13,667 | $911 |
| Long return visit (40+ min) | 23 | $6,140 | $153 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $2,493 | $178 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,352 | $138 |
See all 10 services
| Return visit (30+ min) | 76 | $32,003 | $111 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 14 | $13,667 | $911 |
| Long return visit (40+ min) | 23 | $6,140 | $153 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $2,493 | $178 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,352 | $138 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 13 | $863 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $825 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $422 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $340 | $23 |
| Infusion, normal saline solution, 250 cc | 12 | $42 | None |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
Who their Medicare patients are
100 Original Medicare patients in 2024. Average age 79 · 85 and older 26% · Women 49% · Also on Medicaid 21% · Health risk score 1.73. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 71% · Diabetes 49% · Atrial fibrillation 44% · Heart failure 41% · Chronic kidney disease 40% · Stroke 20% · Cancer 19% · COPD 14% · Depression 12%.
The office billed $200,580, Medicare allowed $118,632 and paid $88,929; for 706 services of 50 kinds; $72 of it was for drugs given in the office and $88,856 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 100 | 706 | 79 | 1.73 | $200,580 | $88,929 |
| 2023 | 125 | 773 | 78 | 1.90 | $214,013 | $96,275 |
| 2022 | 146 | 950 | 76 | 2.19 | $252,785 | $114,389 |
| 2021 | 141 | 1,060 | 78 | 2.25 | $232,900 | $110,210 |
| 2020 | 139 | 1,281 | 78 | 1.72 | $251,401 | $109,391 |
| 2019 | 179 | 2,055 | 79 | 1.89 | $350,687 | $149,826 |
| 2018 | 139 | 1,889 | 78 | 1.89 | $270,110 | $108,850 |
| 2017 | 155 | 1,572 | 79 | 1.74 | $291,862 | $124,316 |
| 2016 | 138 | 1,884 | 79 | 1.54 | $274,163 | $120,034 |
| 2015 | 148 | 1,854 | 80 | 1.76 | $299,771 | $136,919 |
| 2014 | 168 | 2,991 | 79 | 1.62 | $388,019 | $178,007 |
| 2013 | 171 | 1,537 | 79 | 1.52 | $322,845 | $154,146 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 85 | $33,007 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $5,619 | $156 |
| Critical care, first 30-74 minutes | 13 | $3,383 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $3,137 | $71 |
| Long return visit (40+ min) | 12 | $2,896 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,787 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $283 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $268 | $11 |
| Electrocardiogram (ecg) 1 to 3 leads | 16 | $130 | $6 |
2022: 14 services
| Return visit (30+ min) | 81 | $34,737 | $108 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 11 | $12,940 | $995 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $11,301 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $4,376 | $64 |
| Critical care, first 30-74 minutes | 16 | $4,075 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,712 | $93 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,437 | $215 |
| Long return visit (40+ min) | 12 | $3,278 | $164 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $2,315 | $210 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $578 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $338 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $306 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $297 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $227 | $13 |
2021: 11 services
| Return visit (30+ min) | 79 | $37,360 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,928 | $182 |
| Critical care, first 30-74 minutes | 14 | $7,889 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $4,992 | $66 |
| Long return visit (40+ min) | 12 | $4,497 | $167 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,456 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,362 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 25 | $573 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $343 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $230 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $216 | $11 |
2020: 15 services
| Return visit (30+ min) | 90 | $31,158 | $92 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 12 | $19,592 | $1,633 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 12 | $7,768 | $324 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,244 | $181 |
| Critical care, first 30-74 minutes | 16 | $5,787 | $200 |
| Long return visit (40+ min) | 15 | $4,585 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,648 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,103 | $96 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $1,837 | $167 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 17 | $1,166 | $69 |
| Influenza vaccine split virus, preservative free | 16 | $751 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $408 | $17 |
| Administration of influenza virus vaccine | 19 | $397 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $202 | $11 |
| Infusion, normal saline solution, 250 cc | 16 | $50 | None |
2019: 15 services
| Return visit (30+ min) | 104 | $42,785 | $93 |
| Critical care, first 30-74 minutes | 34 | $14,052 | $195 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $12,777 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $7,481 | $65 |
| Long return visit (40+ min) | 30 | $6,498 | $123 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $4,506 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,904 | $93 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,368 | $98 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,247 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 14 | $1,014 | $68 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $470 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $454 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $302 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $203 | $14 |
| Infusion, normal saline solution, 250 cc | 12 | $41 | None |
2018: 15 services
| Return visit (30+ min) | 104 | $39,992 | $88 |
| Long return visit (40+ min) | 28 | $7,269 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,882 | $176 |
| Critical care, first 30-74 minutes | 13 | $3,992 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,792 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,635 | $91 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 15 | $1,493 | $36 |
| Influenza vaccine, inactivated | 21 | $1,141 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 13 | $893 | $64 |
| Administration of influenza virus vaccine | 21 | $566 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $352 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $234 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $214 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $157 | $13 |
| Infusion, normal saline solution, 250 cc | 14 | $44 | None |
2017: 15 services
| Return visit (30+ min) | 115 | $42,741 | $89 |
| Long return visit (40+ min) | 34 | $10,408 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,233 | $164 |
| Critical care, first 30-74 minutes | 13 | $6,283 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $4,527 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $4,022 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $2,802 | $216 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $1,337 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 13 | $890 | $68 |
| Influenza vaccine, inactivated | 15 | $738 | $49 |
| Administration of influenza virus vaccine | 17 | $549 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $431 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $254 | $11 |
| Electrocardiogram (ecg) 1 to 3 leads | 13 | $85 | $5 |
| Infusion, normal saline solution, 250 cc | 13 | $31 | None |
2016: 14 services
| Return visit (30+ min) | 109 | $44,153 | $89 |
| Long return visit (40+ min) | 41 | $10,541 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $7,456 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $4,002 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $2,655 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $2,634 | $203 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 14 | $1,329 | $31 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 16 | $1,089 | $68 |
| Influenza vaccine, inactivated | 20 | $733 | $37 |
| Administration of influenza virus vaccine | 21 | $665 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $534 | $15 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 11 | $395 | None |
| Electrocardiogram (ecg) 1 to 3 leads | 12 | $111 | $6 |
| Infusion, normal saline solution, 250 cc | 16 | $40 | None |
2015: 17 services
| Return visit (30+ min) | 118 | $46,737 | $89 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 12 | $17,273 | $1,439 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $9,542 | $173 |
| Long return visit (40+ min) | 30 | $5,982 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $5,808 | $89 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 12 | $5,367 | $224 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $2,688 | $224 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,893 | $63 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,524 | $95 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $1,524 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | $1,372 | $65 |
| Injection of drug or substance into vein | 20 | $1,140 | $57 |
| Influenza vaccine split virus, preservative free | 21 | $745 | $35 |
| Administration of influenza virus vaccine | 21 | $668 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $560 | $14 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 11 | $370 | None |
| Infusion, normal saline solution, 250 cc | 20 | $35 | None |
2014: 18 services
| Return visit (30+ min) | 134 | $59,612 | $91 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 20 | $29,195 | $1,460 |
| Critical care, first 30-74 minutes | 11 | $9,969 | $195 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $9,684 | $170 |
| Long return visit (40+ min) | 39 | $8,758 | $125 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 20 | $8,467 | $229 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $6,562 | $92 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 25 | $3,120 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 20 | $2,886 | $34 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,800 | $97 |
| New patient visit (60+ min) | 11 | $1,910 | $174 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | $1,466 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,025 | $64 |
| Influenza vaccine split virus, preservative free | 23 | $752 | $33 |
| Administration of influenza virus vaccine | 24 | $747 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $496 | $15 |
| Electrocardiogram (ecg) 1 to 3 leads | 12 | $98 | $6 |
| Infusion, normal saline solution, 250 cc | 25 | $42 | None |
2013: 18 services
| Return visit (30+ min) | 133 | $57,165 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $12,133 | $173 |
| Long return visit (40+ min) | 54 | $11,374 | $125 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 15 | $7,719 | $515 |
| Critical care, first 30-74 minutes | 14 | $5,355 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $4,751 | $90 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 15 | $3,747 | $129 |
| Hospital discharge day management, more than 30 minutes | 25 | $3,314 | $95 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 24 | $3,111 | $32 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $2,455 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,299 | $62 |
| Administration of influenza virus vaccine | 51 | $1,704 | $32 |
| New patient visit (45+ min) | 12 | $1,394 | $116 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 15 | $1,006 | $67 |
| Measurement of heart blood flow and respiration | 26 | $946 | $26 |
| Short return visit (20+ min) | 12 | $892 | $69 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 48 | $591 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 25 | $529 | $18 |
Drugs they prescribed that Part D paid
$226,974
Pharmacies billed $226,974 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (14 of 1,113) in 2024. A higher opioid share than 9 in 10 peers; the typical cardiology clinician is at 0%.
869 generic and fewer than 11 brand-name prescriptions · $226,974 in drug cost · 21 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 40 | $45,390 | $1,135 |
| Xarelto | 22 | $22,623 | $1,028 |
| Jardiance | 17 | $21,882 | $1,287 |
| Entresto | 16 | $19,937 | $1,246 |
| Verquvo | 25 | $18,210 | $728 |
See all 32 drugs
| Eliquis | 40 | $45,390 | $1,135 |
| Xarelto | 22 | $22,623 | $1,028 |
| Jardiance | 17 | $21,882 | $1,287 |
| Entresto | 16 | $19,937 | $1,246 |
| Verquvo | 25 | $18,210 | $728 |
| Farxiga | 15 | $10,314 | $688 |
| Brilinta | 17 | $10,143 | $597 |
| Testosterone | 11 | $9,018 | $820 |
| Dofetilide | 26 | $5,484 | $211 |
| Flecainide Acetate | 23 | $1,569 | $68 |
| Atorvastatin | 89 | $1,123 | $13 |
| Ranolazine Er | 11 | $980 | $89 |
| Rosuvastatin | 23 | $884 | $38 |
| Dutasteride | 12 | $861 | $72 |
| Metoprolol | 30 | $715 | $24 |
| Nitroglycerin | 11 | $699 | $64 |
| Bupropion Xl | 12 | $693 | $58 |
| Clonidine | 14 | $689 | $49 |
| Amlodipine Besylate | 61 | $579 | $9 |
| Clopidogrel | 33 | $450 | $14 |
| Levothyroxine | 29 | $447 | $15 |
| Paroxetine Cr | 11 | $401 | $36 |
| Pantoprazole | 16 | $367 | $23 |
| Oxybutynin Chloride Er | 19 | $335 | $18 |
| Glipizide Er | 13 | $276 | $21 |
| Carvedilol | 20 | $188 | $9 |
| Spironolactone | 21 | $188 | $9 |
| Torsemide | 11 | $162 | $15 |
| Losartan | 26 | $148 | $6 |
| Furosemide | 16 | $126 | $8 |
| Alprazolam | 12 | $112 | $9 |
| Metoprolol | 21 | $88 | $4 |
Year by year
| 2024 | 1,113 | 96 | 1% (14) | None | $226,974 |
| 2023 | 1,111 | 94 | 1% (14) | None | $200,623 |
| 2022 | 1,092 | 92 | None | None | $166,278 |
| 2021 | 1,044 | 85 | None | 19% | $165,344 |
| 2020 | 1,115 | 93 | None | 18% | $157,319 |
| 2019 | 1,122 | 92 | None | 15% | $118,277 |
| 2018 | 1,256 | 87 | None | 18% | $130,020 |
| 2017 | 1,240 | 92 | 2% (25) | 21% | $151,850 |
| 2016 | 1,238 | 80 | 2% (24) | 27% | $179,637 |
| 2015 | 1,359 | 86 | 2% (22) | 32% | $197,672 |
| 2014 | 1,474 | 90 | 1% (17) | 34% | $168,289 |
| 2013 | 1,277 | 89 | 1% (14) | 36% | $131,280 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Eliquis | 25 | $31,296 | $1,252 |
| Entresto | 21 | $19,790 | $942 |
| Xarelto | 15 | $18,248 | $1,217 |
| Brilinta | 25 | $17,805 | $712 |
| Flecainide Acetate | 23 | $2,509 | $109 |
| Clonidine | 19 | $1,861 | $98 |
| Atorvastatin | 103 | $1,592 | $15 |
| Paroxetine Cr | 13 | $1,343 | $103 |
| Rosuvastatin | 34 | $1,288 | $38 |
| Metoprolol | 33 | $941 | $29 |
| Potassium Chloride | 15 | $822 | $55 |
| Bumetanide | 16 | $784 | $49 |
| Clopidogrel | 26 | $693 | $27 |
| Scopolamine | 11 | $630 | $57 |
| Oxybutynin Chloride Er | 21 | $581 | $28 |
| Amlodipine Besylate | 65 | $560 | $9 |
| Digoxin | 15 | $550 | $37 |
| Pantoprazole | 15 | $471 | $31 |
| Glipizide Er | 12 | $445 | $37 |
| Losartan | 42 | $416 | $10 |
| Spironolactone | 15 | $405 | $27 |
| Carvedilol | 23 | $364 | $16 |
| Levothyroxine | 21 | $314 | $15 |
| Lisinopril | 16 | $304 | $19 |
| Metoprolol | 22 | $292 | $13 |
| Sotalol | 12 | $266 | $22 |
| Alprazolam | 21 | $186 | $9 |
| Furosemide | 16 | $151 | $9 |
| Metformin | 12 | $111 | $9 |
| Hydrochlorothiazide | 15 | $45 | $3 |
| Quetiapine | 13 | $17 | $1 |
2022: 30 drugs
| Entresto | 34 | $21,525 | $633 |
| Eliquis | 14 | $15,471 | $1,105 |
| Xarelto | 12 | $11,024 | $919 |
| Brilinta | 23 | $10,535 | $458 |
| Clonidine | 13 | $5,573 | $429 |
| Flecainide Acetate | 26 | $3,538 | $136 |
| Atorvastatin | 95 | $1,083 | $11 |
| Rosuvastatin | 32 | $1,008 | $32 |
| Metoprolol | 36 | $881 | $24 |
| Ezetimibe | 19 | $756 | $40 |
| Bumetanide | 20 | $622 | $31 |
| Clopidogrel | 31 | $612 | $20 |
| Sotalol | 26 | $503 | $19 |
| Oxybutynin Chloride Er | 18 | $489 | $27 |
| Pantoprazole | 24 | $384 | $16 |
| Digoxin | 11 | $373 | $34 |
| Amlodipine Besylate | 65 | $369 | $6 |
| Amiodarone | 11 | $362 | $33 |
| Carvedilol | 20 | $348 | $17 |
| Triamterene-Hydrochlorothiazid | 11 | $332 | $30 |
| Alprazolam | 16 | $299 | $19 |
| Metoprolol | 29 | $253 | $9 |
| Potassium Chloride | 14 | $237 | $17 |
| Losartan | 27 | $208 | $8 |
| Levothyroxine | 11 | $201 | $18 |
| Isosorbide Mononitrate Er | 13 | $190 | $15 |
| Lisinopril | 17 | $153 | $9 |
| Furosemide | 14 | $106 | $8 |
| Quetiapine | 15 | $73 | $5 |
| Hydrochlorothiazide | 13 | $68 | $5 |
2021: 28 drugs
| Xarelto | 21 | $23,198 | $1,105 |
| Entresto | 28 | $16,333 | $583 |
| Eliquis | 18 | $15,004 | $834 |
| Brilinta | 26 | $10,909 | $420 |
| Corlanor | 11 | $5,653 | $514 |
| Flecainide Acetate | 23 | $2,927 | $127 |
| Atorvastatin | 92 | $1,333 | $14 |
| Rosuvastatin | 27 | $1,183 | $44 |
| Ezetimibe | 17 | $1,181 | $69 |
| Sotalol | 23 | $928 | $40 |
| Metoprolol | 33 | $858 | $26 |
| Clopidogrel | 48 | $687 | $14 |
| Digoxin | 13 | $625 | $48 |
| Olmesartan Medoxomil | 13 | $574 | $44 |
| Pantoprazole | 30 | $547 | $18 |
| Bisoprolol | 11 | $524 | $48 |
| Diltiazem 24hr Er (Cd) | 14 | $492 | $35 |
| Warfarin | 18 | $306 | $17 |
| Amlodipine Besylate | 40 | $293 | $7 |
| Levothyroxine | 23 | $287 | $12 |
| Alprazolam | 15 | $277 | $18 |
| Carvedilol | 19 | $253 | $13 |
| Isosorbide Mononitrate Er | 15 | $242 | $16 |
| Irbesartan | 12 | $152 | $13 |
| Lisinopril | 25 | $137 | $5 |
| Spironolactone | 11 | $114 | $10 |
| Hydrochlorothiazide | 17 | $58 | $3 |
| Clonidine | 11 | $40 | $4 |
2020: 35 drugs
| Eliquis | 20 | $16,942 | $847 |
| Brilinta | 25 | $14,159 | $566 |
| Xarelto | 12 | $13,371 | $1,114 |
| Januvia | 14 | $11,988 | $856 |
| Bystolic | 22 | $6,428 | $292 |
| Prasugrel | 11 | $4,150 | $377 |
| Propafenone Hcl Er | 14 | $2,874 | $205 |
| Rosuvastatin | 38 | $2,543 | $67 |
| Amiodarone | 23 | $2,429 | $106 |
| Atorvastatin | 85 | $1,367 | $16 |
| Sotalol | 27 | $1,023 | $38 |
| Clopidogrel | 55 | $967 | $18 |
| Flecainide Acetate | 13 | $824 | $63 |
| Metoprolol | 34 | $742 | $22 |
| Ezetimibe | 17 | $711 | $42 |
| Nifedipine Er | 14 | $674 | $48 |
| Bisoprolol | 11 | $623 | $57 |
| Digoxin | 13 | $622 | $48 |
| Olmesartan Medoxomil | 14 | $602 | $43 |
| Levothyroxine | 24 | $558 | $23 |
| Pantoprazole | 26 | $498 | $19 |
| Alprazolam | 15 | $367 | $24 |
| Nitroglycerin | 14 | $332 | $24 |
| Amlodipine Besylate | 51 | $316 | $6 |
| Carvedilol | 24 | $314 | $13 |
| Warfarin | 31 | $288 | $9 |
| Losartan | 13 | $237 | $18 |
| Isosorbide Mononitrate Er | 18 | $220 | $12 |
| Torsemide | 15 | $205 | $14 |
| Irbesartan | 12 | $142 | $12 |
| Spironolactone | 16 | $134 | $8 |
| Furosemide | 13 | $104 | $8 |
| Lisinopril | 14 | $64 | $5 |
| Hydrochlorothiazide | 12 | $56 | $5 |
| Clonidine | 16 | $47 | $3 |
2019: 31 drugs
| Brilinta | 14 | $6,200 | $443 |
| Bystolic | 15 | $5,104 | $340 |
| Telmisartan | 16 | $4,353 | $272 |
| Rosuvastatin | 30 | $2,640 | $88 |
| Atorvastatin | 87 | $1,961 | $23 |
| Amiodarone | 12 | $1,678 | $140 |
| Sotalol | 28 | $1,105 | $39 |
| Nitroglycerin | 20 | $1,080 | $54 |
| Bisoprolol | 24 | $916 | $38 |
| Flecainide Acetate | 14 | $900 | $64 |
| Ezetimibe | 18 | $794 | $44 |
| Clopidogrel | 54 | $774 | $14 |
| Levothyroxine | 23 | $764 | $33 |
| Metoprolol | 24 | $714 | $30 |
| Carvedilol | 27 | $574 | $21 |
| Amlodipine Besylate | 51 | $469 | $9 |
| Lorazepam | 19 | $318 | $17 |
| Torsemide | 16 | $315 | $20 |
| Losartan | 15 | $272 | $18 |
| Warfarin | 38 | $260 | $7 |
| Cartia Xt | 11 | $244 | $22 |
| Alprazolam | 17 | $243 | $14 |
| Irbesartan | 15 | $241 | $16 |
| Isosorbide Mononitrate Er | 21 | $199 | $9 |
| Furosemide | 25 | $198 | $8 |
| Pantoprazole | 16 | $186 | $12 |
| Spironolactone | 15 | $116 | $8 |
| Metformin Hcl Er | 11 | $72 | $7 |
| Metoprolol | 11 | $68 | $6 |
| Clonidine | 16 | $33 | $2 |
| Lisinopril | 14 | $30 | $2 |
2018: 37 drugs
| Pradaxa | 13 | $8,735 | $672 |
| Brilinta | 12 | $7,450 | $621 |
| Multaq | 11 | $7,018 | $638 |
| Bystolic | 19 | $5,308 | $279 |
| Telmisartan | 27 | $4,876 | $181 |
| Crestor | 12 | $3,101 | $258 |
| Rosuvastatin | 29 | $1,934 | $67 |
| Atorvastatin | 95 | $1,811 | $19 |
| Ezetimibe | 20 | $1,443 | $72 |
| Coumadin | 11 | $1,403 | $128 |
| Sotalol | 50 | $1,114 | $22 |
| Nitroglycerin | 28 | $1,000 | $36 |
| Clopidogrel | 46 | $906 | $20 |
| Olmesartan Medoxomil | 15 | $813 | $54 |
| Ventolin Hfa | 14 | $766 | $55 |
| Flecainide Acetate | 20 | $722 | $36 |
| Levothyroxine | 19 | $648 | $34 |
| Digox | 12 | $546 | $46 |
| Isosorbide Mononitrate Er | 31 | $518 | $17 |
| Gabapentin | 15 | $513 | $34 |
| Metoprolol | 13 | $473 | $36 |
| Amlodipine Besylate | 65 | $438 | $7 |
| Carvedilol | 23 | $424 | $18 |
| Irbesartan | 21 | $421 | $20 |
| Warfarin | 36 | $411 | $11 |
| Cilostazol | 11 | $393 | $36 |
| Potassium Chloride | 15 | $301 | $20 |
| Lorazepam | 14 | $274 | $20 |
| Metformin Hcl Er | 23 | $264 | $11 |
| Pantoprazole | 19 | $263 | $14 |
| Spironolactone | 13 | $157 | $12 |
| Levofloxacin | 17 | $154 | $9 |
| Furosemide | 32 | $131 | $4 |
| Losartan | 13 | $95 | $7 |
| Benazepril | 11 | $64 | $6 |
| Lisinopril | 21 | $32 | $2 |
| Clonidine | 11 | $25 | $2 |
2017: 38 drugs
| Pradaxa | 18 | $10,305 | $572 |
| Effient | 13 | $9,898 | $761 |
| Brilinta | 14 | $9,676 | $691 |
| Zetia | 11 | $5,251 | $477 |
| Bystolic | 16 | $3,586 | $224 |
| Midodrine | 13 | $2,499 | $192 |
| Rosuvastatin | 33 | $2,489 | $75 |
| Coumadin | 15 | $2,427 | $162 |
| Olmesartan Medoxomil | 18 | $1,789 | $99 |
| Nitroglycerin | 28 | $1,409 | $50 |
| Atorvastatin | 59 | $1,332 | $23 |
| Sotalol | 54 | $1,264 | $23 |
| Digox | 11 | $1,206 | $110 |
| Flecainide Acetate | 20 | $1,007 | $50 |
| Metoprolol | 24 | $747 | $31 |
| Levothyroxine | 23 | $643 | $28 |
| Amlodipine Besylate | 75 | $610 | $8 |
| Cilostazol | 11 | $509 | $46 |
| Nifedipine Er | 12 | $496 | $41 |
| Isosorbide Mononitrate Er | 25 | $488 | $20 |
| Clopidogrel | 35 | $452 | $13 |
| Levofloxacin | 12 | $390 | $33 |
| Bupropion | 12 | $373 | $31 |
| Irbesartan | 15 | $360 | $24 |
| Warfarin | 17 | $295 | $17 |
| Carvedilol | 25 | $272 | $11 |
| Lorazepam | 15 | $263 | $18 |
| Spironolactone | 16 | $197 | $12 |
| Diclofenac | 13 | $188 | $14 |
| Clonidine | 11 | $167 | $15 |
| Simvastatin | 24 | $140 | $6 |
| Triamterene-Hydrochlorothiazid | 14 | $119 | $8 |
| Furosemide | 28 | $110 | $4 |
| Citalopram Hbr | 12 | $96 | $8 |
| Omeprazole | 14 | $92 | $7 |
| Hydrochlorothiazide | 17 | $50 | $3 |
| Lisinopril | 16 | $47 | $3 |
| Benazepril | 11 | $39 | $4 |
2016: 34 drugs
| Ativan | 12 | $32,654 | $2,721 |
| Crestor | 40 | $11,571 | $289 |
| Pradaxa | 14 | $8,671 | $619 |
| Zetia | 14 | $4,903 | $350 |
| Benicar | 14 | $4,873 | $348 |
| Edarbyclor | 12 | $2,282 | $190 |
| Coumadin | 16 | $1,668 | $104 |
| Rosuvastatin | 20 | $1,610 | $81 |
| Propafenone | 12 | $1,302 | $108 |
| Atorvastatin | 58 | $1,209 | $21 |
| Metoprolol | 26 | $857 | $33 |
| Sotalol | 51 | $818 | $16 |
| Amlodipine Besylate | 59 | $734 | $12 |
| Cilostazol | 17 | $729 | $43 |
| Levothyroxine | 28 | $727 | $26 |
| Nitrostat | 19 | $642 | $34 |
| Amlodipine Besylate-Benazepril | 13 | $572 | $44 |
| Clopidogrel | 47 | $511 | $11 |
| Isosorbide Mononitrate Er | 17 | $398 | $23 |
| Carvedilol | 32 | $382 | $12 |
| Lorazepam | 11 | $344 | $31 |
| Pantoprazole | 20 | $323 | $16 |
| Diclofenac | 12 | $274 | $23 |
| Tramadol | 13 | $201 | $15 |
| Furosemide | 35 | $195 | $6 |
| Tamsulosin | 11 | $181 | $16 |
| Triamterene-Hydrochlorothiazid | 13 | $121 | $9 |
| Omeprazole | 11 | $120 | $11 |
| Simvastatin | 15 | $118 | $8 |
| Spironolactone | 12 | $117 | $10 |
| Lisinopril | 14 | $116 | $8 |
| Ranitidine | 15 | $96 | $6 |
| Zolpidem | 21 | $55 | $3 |
| Metformin | 14 | $52 | $4 |
2015: 40 drugs
| Betapace | 16 | $16,111 | $1,007 |
| Crestor | 47 | $12,820 | $273 |
| Pradaxa | 30 | $12,226 | $408 |
| Zetia | 21 | $8,072 | $384 |
| Ranexa | 12 | $8,008 | $667 |
| Benicar | 20 | $4,886 | $244 |
| Coreg Cr | 15 | $3,361 | $224 |
| Vytorin | 12 | $3,148 | $262 |
| Edarbyclor | 14 | $2,088 | $149 |
| Bystolic | 17 | $2,036 | $120 |
| Coumadin | 21 | $1,863 | $89 |
| Propafenone | 14 | $1,736 | $124 |
| Pravastatin | 28 | $1,033 | $37 |
| Atorvastatin | 52 | $907 | $17 |
| Spironolactone-Hctz | 15 | $843 | $56 |
| Sotalol | 40 | $807 | $20 |
| Levothyroxine | 31 | $752 | $24 |
| Isosorbide Mononitrate Er | 22 | $659 | $30 |
| Metoprolol | 19 | $605 | $32 |
| Nitrostat | 24 | $541 | $23 |
| Amlodipine Besylate-Benazepril | 12 | $535 | $45 |
| Omeprazole | 22 | $532 | $24 |
| Clopidogrel | 40 | $499 | $12 |
| Digoxin | 14 | $493 | $35 |
| Amlodipine Besylate | 55 | $466 | $8 |
| Carvedilol | 26 | $461 | $18 |
| Tamsulosin | 12 | $445 | $37 |
| Warfarin | 28 | $362 | $13 |
| Nifedipine Er | 13 | $314 | $24 |
| Furosemide | 39 | $214 | $5 |
| Lorazepam | 11 | $203 | $18 |
| Simvastatin | 12 | $176 | $15 |
| Spironolactone | 21 | $167 | $8 |
| Clonidine | 13 | $166 | $13 |
| Diclofenac | 12 | $141 | $12 |
| Citalopram Hbr | 12 | $140 | $12 |
| Metoprolol | 12 | $132 | $11 |
| Lisinopril | 17 | $118 | $7 |
| Alprazolam | 15 | $92 | $6 |
| Ranitidine | 14 | $88 | $6 |
2014: 53 drugs
| Crestor | 39 | $9,174 | $235 |
| Pradaxa | 26 | $8,792 | $338 |
| Ranexa | 12 | $7,118 | $593 |
| Zetia | 24 | $6,893 | $287 |
| Betapace | 14 | $6,597 | $471 |
| Propafenone Hcl Er | 11 | $6,569 | $597 |
| Effient | 20 | $6,402 | $320 |
| Azilect | 12 | $6,152 | $513 |
| Benicar | 23 | $4,963 | $216 |
| Coreg Cr | 19 | $4,098 | $216 |
| Aggrenox | 11 | $3,570 | $325 |
| Brilinta | 13 | $3,331 | $256 |
| Celebrex | 11 | $2,731 | $248 |
| Azor | 12 | $1,976 | $165 |
| Coumadin | 24 | $1,573 | $66 |
| Edarbyclor | 12 | $1,419 | $118 |
| Clopidogrel | 37 | $1,412 | $38 |
| Edarbi | 12 | $1,384 | $115 |
| Pravastatin | 36 | $1,239 | $34 |
| Metoprolol | 28 | $1,091 | $39 |
| Digox | 11 | $1,082 | $98 |
| Cholestyramine | 14 | $1,016 | $73 |
| Atorvastatin | 52 | $751 | $14 |
| Omeprazole | 13 | $693 | $53 |
| Spironolactone-Hctz | 22 | $668 | $30 |
| Levothyroxine | 29 | $624 | $22 |
| Amlodipine Besylate-Benazepril | 11 | $615 | $56 |
| Nitrostat | 27 | $534 | $20 |
| Bisoprolol | 11 | $515 | $47 |
| Sotalol | 21 | $507 | $24 |
| Amlodipine Besylate | 48 | $485 | $10 |
| Digoxin | 13 | $472 | $36 |
| Warfarin | 32 | $390 | $12 |
| Pantoprazole | 16 | $380 | $24 |
| Nifedipine Er | 14 | $366 | $26 |
| Spironolactone | 27 | $325 | $12 |
| Carvedilol | 28 | $310 | $11 |
| Potassium Chloride | 12 | $290 | $24 |
| Ropinirole | 13 | $217 | $17 |
| Diclofenac | 12 | $216 | $18 |
| Torsemide | 12 | $166 | $14 |
| Furosemide | 41 | $159 | $4 |
| Metoprolol | 12 | $151 | $13 |
| Lorazepam | 16 | $143 | $9 |
| Gabapentin | 12 | $139 | $12 |
| Ranitidine | 16 | $138 | $9 |
| Clonazepam | 13 | $122 | $9 |
| Simvastatin | 13 | $113 | $9 |
| Hydrochlorothiazide | 15 | $103 | $7 |
| Citalopram Hbr | 12 | $101 | $8 |
| Indapamide | 12 | $86 | $7 |
| Alprazolam | 12 | $83 | $7 |
| Metformin | 11 | $58 | $5 |
2013: 41 drugs
| Crestor | 52 | $12,274 | $236 |
| Ranexa | 19 | $9,099 | $479 |
| Effient | 16 | $6,766 | $423 |
| Azilect | 12 | $5,444 | $454 |
| Betapace | 11 | $4,917 | $447 |
| Seroquel Xr | 12 | $4,601 | $383 |
| Propafenone | 17 | $3,782 | $222 |
| Zetia | 15 | $3,263 | $218 |
| Clopidogrel | 40 | $3,056 | $76 |
| Pradaxa | 11 | $2,908 | $264 |
| Celebrex | 14 | $2,378 | $170 |
| Coumadin | 27 | $2,065 | $76 |
| Atorvastatin | 47 | $1,949 | $41 |
| Metoprolol | 23 | $1,719 | $75 |
| Benicar | 11 | $1,601 | $146 |
| Sotalol | 41 | $1,125 | $27 |
| Aldactazide | 12 | $911 | $76 |
| Pravastatin | 34 | $834 | $25 |
| Spironolactone-Hctz | 31 | $826 | $27 |
| Labetalol | 14 | $765 | $55 |
| Lanoxin | 12 | $689 | $57 |
| Amlodipine Besylate | 38 | $556 | $15 |
| Pantoprazole | 16 | $432 | $27 |
| Synthroid | 12 | $418 | $35 |
| Losartan | 15 | $392 | $26 |
| Warfarin | 33 | $378 | $11 |
| Nitrostat | 18 | $324 | $18 |
| Levothyroxine | 24 | $308 | $13 |
| Ropinirole | 13 | $296 | $23 |
| Terazosin | 13 | $279 | $21 |
| Lorazepam | 29 | $256 | $9 |
| Digox | 24 | $242 | $10 |
| Torsemide | 13 | $202 | $16 |
| Gabapentin | 14 | $192 | $14 |
| Ranitidine | 18 | $156 | $9 |
| Hydrochlorothiazide | 19 | $131 | $7 |
| Alprazolam | 19 | $130 | $7 |
| Levofloxacin | 12 | $116 | $10 |
| Furosemide | 23 | $86 | $4 |
| Atenolol | 11 | $62 | $6 |
| Indapamide | 11 | $46 | $4 |
Money from drug and device companies
$569 in 2025
| 2025 | 8 | 19 | None | $569 |
| 2024 | 11 | 28 | None | $809 |
| 2023 | 11 | 33 | None | $1,149 |
| 2022 | 9 | 21 | None | $869 |
| 2021 | 4 | 7 | None | $574 |
| 2020 | 10 | 25 | None | $522 |
| 2019 | 13 | 74 | None | $1,484 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $144 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $122 | 5 payments
|
| Boston Scientific | Watchman Flx | $82 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $81 | 3 payments
|
| Amgen | Repatha | $49 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $34 | 2 payments
|
See all 19 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-18 | Kerendia | $14 |
| Bayer Healthcare Pharmaceuticals | Education · 2025-11-17 | Kerendia | $20 |
| Merck Sharp & Dohme | Meals · 2025-11-05 | Capvaxive | $26 |
| Novartis Pharmaceuticals | Meals · 2025-10-15 | Leqvio | $32 |
| Heartflow | Meals · 2025-09-16 | Ffrct | $42 |
| Heartflow | Meals · 2025-09-16 | Ffrct | $102 |
| Merck Sharp & Dohme | Meals · 2025-09-09 | Verquvo | $28 |
| GlaxoSmithKline | Meals · 2025-08-19 | Shingrix | $28 |
| Novartis Pharmaceuticals | Meals · 2025-08-12 | Leqvio | $20 |
| Merck Sharp & Dohme | Meals · 2025-07-17 | Verquvo | $21 |
| Boston Scientific | Meals · 2025-07-03 | Watchman Flx | $21 |
| Amgen | Meals · 2025-06-04 | Repatha | $23 |
| Merck Sharp & Dohme | Meals · 2025-05-28 | Verquvo | $22 |
| Boston Scientific | Meals · 2025-04-22 | Watchman Flx | $38 |
| Merck Sharp & Dohme | Meals · 2025-03-24 | Verquvo | $26 |
| Novartis Pharmaceuticals | Meals · 2025-03-12 | Leqvio | $29 |
| Amgen | Meals · 2025-02-27 | Repatha | $27 |
| Pfizer | Meals · 2025-02-24 | Eliquis | $28 |
| Boston Scientific | Meals · 2025-02-11 | Watchman Flx | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $809
| Pfizer | Eliquis | $150 | 7 payments
|
| Esperion Therapeutics | Nexlizet | $140 | 2 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $96 | 1 payment
|
| Boston Scientific | Watchman Flx | $87 | 4 payments
|
| Novartis Pharmaceuticals | Leqvio | $87 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $70 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $58 | 3 payments
|
| Amgen | Repatha | $40 | 2 payments
|
| Abbott Laboratories | Amplatzer Amulet | $33 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $27 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $21 | 1 payment
|
2023: $1,149
| Boston Scientific | Watchman Flx | $199 | 4 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $197 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $187 | 4 payments
|
| Novartis Pharmaceuticals | Leqvio | $146 | 8 payments
|
| Novo Nordisk | None | $125 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $109 | 6 payments
|
| Pfizer | Eliquis | $79 | 3 payments
|
| Amgen | Repatha | $40 | 2 payments
|
| Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor | $26 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $26 | 1 payment
|
| Esperion Therapeutics | Nexletol | $14 | 1 payment
|
2022: $869
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $231 | 2 payments
|
| Amgen | Repatha | $179 | 6 payments
|
| Merck Sharp & Dohme | Verquvo | $157 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $114 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $75 | 4 payments
|
| Pfizer | Eliquis | $50 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $28 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $18 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $16 | 1 payment
|
2021: $574
| Philips Electronics North America | (8333) Igt D Coronary | $251 | 2 payments
|
| Boston Scientific | Watchman | $193 | 3 payments
|
| Novo Nordisk | Ozempic | $97 | 1 payment
|
| Pfizer | Eliquis | $33 | 1 payment
|
2020: $522
| Amarin Pharma | Vascepa | $226 | 13 payments
|
| Janssen Pharmaceuticals | Xarelto | $64 | 3 payments
|
| Biotronik | None | $49 | 1 payment
|
| Amgen | Repatha | $46 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $31 | 1 payment
|
| Boston Scientific | Watchman | $25 | 1 payment
|
| Abbott Laboratories | Assurity Pacemaker | $22 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $21 | 1 payment
|
| Esperion Therapeutics | Nexletol | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $18 | 1 payment
|
2019: $1,484
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $304 | 43 payments
|
| Biotronik | None | $228 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $154 | 8 payments
|
| Philips Electronics North America | Igt D Coronary | $150 | 1 payment
|
| Lundbeck | Northera | $125 | 1 payment
|
| Sanofi-Aventis U.S. | Praluent | $125 | 1 payment
|
| Portola Pharmaceuticals | Andexxa | $125 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $81 | 5 payments
|
| Pfizer | Chantix | $71 | 3 payments
|
| Amarin Pharma | Vascepa | $62 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $22 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $20 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $18 | 1 payment
|
Professional record
- NPI
- 1649348350
- Licence
- CA A35335California A35335: Delinquent · expires 2025-12-31
- Trained
- Ohio State University College of Medicine, 1960
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 173 N Morrison Ave, Suite C, San Jose, CA, 95126
- NPI first listed
- 2006-12-01
- NPI last updated
- 2012-04-26
This is when the NPI record was last certified, not a medical board exam.